Roth Capital Transfers Coverage of Apollo Endosurgery (APEN), Downgrades to Neutral
Tweet Send to a Friend
Roth Capital downgraded Apollo Endosurgery (NASDAQ: APEN) from Buy to Neutral with a price target of $8.75 (from $9.50) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
